- Home
- ACIU vs AFRI Comparison
ACIU vs AFRI Comparison
Compare ACIU & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- AFRI
- Stock Information
- Founded
- ACIU 2003
- AFRI 1943
- Country
- ACIU Switzerland
- AFRI Gibraltar
- Employees
- ACIU N/A
- AFRI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- AFRI Packaged Foods
- Sector
- ACIU Health Care
- AFRI Consumer Staples
- Exchange
- ACIU Nasdaq
- AFRI Nasdaq
- Market Cap
- ACIU 332.4M
- AFRI 269.6M
- IPO Year
- ACIU 2016
- AFRI N/A
- Fundamental
- Price
- ACIU $2.71
- AFRI $10.25
- Analyst Decision
- ACIU Strong Buy
- AFRI
- Analyst Count
- ACIU 2
- AFRI 0
- Target Price
- ACIU $12.00
- AFRI N/A
- AVG Volume (30 Days)
- ACIU 132.5K
- AFRI 10.1K
- Earning Date
- ACIU 11-05-2024
- AFRI 01-07-2025
- Dividend Yield
- ACIU N/A
- AFRI N/A
- EPS Growth
- ACIU N/A
- AFRI N/A
- EPS
- ACIU N/A
- AFRI N/A
- Revenue
- ACIU $48,505,404.00
- AFRI $305,476,000.00
- Revenue This Year
- ACIU $85.33
- AFRI N/A
- Revenue Next Year
- ACIU $80.69
- AFRI N/A
- P/E Ratio
- ACIU N/A
- AFRI N/A
- Revenue Growth
- ACIU 4097200.00
- AFRI 5.42
- 52 Week Low
- ACIU $2.25
- AFRI $9.63
- 52 Week High
- ACIU $5.14
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- ACIU 27.22
- AFRI 47.77
- Support Level
- ACIU $2.63
- AFRI $10.00
- Resistance Level
- ACIU $3.07
- AFRI $10.75
- Average True Range (ATR)
- ACIU 0.15
- AFRI 0.21
- MACD
- ACIU -0.04
- AFRI 0.03
- Stochastic Oscillator
- ACIU 8.96
- AFRI 21.33
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.